These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

545 related articles for article (PubMed ID: 22458900)

  • 1. Emerging critical role of molecular testing in diagnostic genitourinary pathology.
    Netto GJ; Cheng L
    Arch Pathol Lab Med; 2012 Apr; 136(4):372-90. PubMed ID: 22458900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular diagnostics in urologic malignancies: a work in progress.
    Netto GJ
    Arch Pathol Lab Med; 2011 May; 135(5):610-21. PubMed ID: 21526959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?
    Netto GJ
    Nat Rev Urol; 2011 Dec; 9(1):41-51. PubMed ID: 22158597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular genetics and genomics progress in urothelial bladder cancer.
    Netto GJ
    Semin Diagn Pathol; 2013 Nov; 30(4):313-20. PubMed ID: 24342287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Molecular diagnostics in urologic oncology. Detection of nucleic acids in urine samples].
    Müller M; Goessl C; Krause H; Miller K
    Urologe A; 2003 May; 42(5):660-8. PubMed ID: 12750801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of recent molecular advances in urologic malignancies: no longer chasing a "mirage"?
    Netto GJ
    Adv Anat Pathol; 2013 May; 20(3):175-203. PubMed ID: 23574774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Updates in Histologic Grading of Urologic Neoplasms.
    Rice-Stitt T; Valencia-Guerrero A; Cornejo KM; Wu CL
    Arch Pathol Lab Med; 2020 Mar; 144(3):335-343. PubMed ID: 32101058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prognostic and predictive molecular markers for urologic cancers].
    Hartmann A; Schlomm T; Bertz S; Heinzelmann J; Hölters S; Simon R; Stoehr R; Junker K
    Urologe A; 2014 Apr; 53(4):491-500. PubMed ID: 24700189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Emergence of Precision Urologic Oncology: A Collaborative Review on Biomarker-driven Therapeutics.
    Barbieri CE; Chinnaiyan AM; Lerner SP; Swanton C; Rubin MA
    Eur Urol; 2017 Feb; 71(2):237-246. PubMed ID: 27567210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TERT- beyond the territory: Usage of PCR-based TERT promoter assay in defining urothelial carcinoma in a case of long-standing prostatic adenocarcinoma.
    Mannan R; Taylor AS; Spratt DE; Chinnaiyan AM; Montgomery JS; Brown NA; Mehra R
    Pathol Res Pract; 2020 Jan; 216(1):152663. PubMed ID: 31630874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
    Mlcochova H; Hezova R; Stanik M; Slaby O
    Urol Oncol; 2014 Jan; 32(1):41.e1-9. PubMed ID: 24035473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Molecular tumor board-urothelial cancer].
    Hupe MC; Gakis G; Seiler R
    Urologe A; 2019 Jul; 58(7):760-767. PubMed ID: 31172245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary MicroRNAs as Biomarkers of Urological Cancers: A Systematic Review.
    Aveta A; Cilio S; Contieri R; Spena G; Napolitano L; Manfredi C; Franco A; Crocerossa F; Cerrato C; Ferro M; Del Giudice F; Verze P; Lasorsa F; Salonia A; Nair R; Walz J; Lucarelli G; Pandolfo SD
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theranostic and prognostic biomarkers: genomic applications in urological malignancies.
    Netto GJ; Epstein JI
    Pathology; 2010 Jun; 42(4):384-94. PubMed ID: 20438413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Cell and Urothelial Carcinoma: Biomarkers for New Treatments.
    Schmidt AL; Siefker-Radtke A; McConkey D; McGregor B
    Am Soc Clin Oncol Educ Book; 2020 Mar; 40():1-11. PubMed ID: 32379987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic and predictive miRNA biomarkers in bladder, kidney and prostate cancer: Where do we stand in biomarker development?
    Schubert M; Junker K; Heinzelmann J
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1673-95. PubMed ID: 26660324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of methylation in urological tumours.
    van der Heijden AG
    Arch Esp Urol; 2013 Jun; 66(5):432-9. PubMed ID: 23793761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of genetic markers in the management of prostate cancer.
    Choudhury AD; Eeles R; Freedland SJ; Isaacs WB; Pomerantz MM; Schalken JA; Tammela TL; Visakorpi T
    Eur Urol; 2012 Oct; 62(4):577-87. PubMed ID: 22695242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selected common diagnostic problems in urologic pathology: perspectives from a large consult service in genitourinary pathology.
    Brimo F; Epstein JI
    Arch Pathol Lab Med; 2012 Apr; 136(4):360-71. PubMed ID: 22458899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.